Literature DB >> 7434132

Fungal infections of the scalp in Western Australia.

R McAleer.   

Abstract

Between 1963 and 1972, 1,212 fungi were isolated from patients with tinea capitis (ringworm of the scalp) in Western Australia. The clinical diagnosis was confirmed by microscopic examination examination and/or culture of hairs, scale or pus. Microsporum canis, a zoophilic fungus, was found to be the most common agent of tinea capitis in Western Australia, causing 1,100 infections and accounting for 90.8% of the total isolates. The highest incidence of M. canis infections occurred in children between the ages of 2 and 8 years. Males accounted for 57.7% of scalp infections, and there were comparatively few cases in either males or females over the age of 10 years. Trichophyton tonsurans was found to be the main cause of endothrix scalp infections in Western Australia.

Entities:  

Mesh:

Year:  1980        PMID: 7434132     DOI: 10.1080/00362178085380331

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  5 in total

Review 1.  Review of animal mycoses in Australia.

Authors:  M D Connole
Journal:  Mycopathologia       Date:  1990-09       Impact factor: 2.574

2.  Isolation of fungi from the pelage of cats and dogs using the hairbrush technique.

Authors:  M F Simpanya; M Baxter
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

3.  Dermatophytes in Portugal (1972-1981).

Authors:  J Cabrita; J Esteves; H Sequeira
Journal:  Mycopathologia       Date:  1984-02-15       Impact factor: 2.574

4.  A survey of dermatophytes isolated from human patients in the United States from 1979 to 1981 with chronological listings of worldwide incidence of five dermatophytes often isolated in the United States.

Authors:  J T Sinski; K Flouras
Journal:  Mycopathologia       Date:  1984-03-15       Impact factor: 2.574

5.  Tinea capitis due to Microsporum canis in infants.

Authors:  I Alteras; E J Feuerman; M Grunwald; D Shvili
Journal:  Mycopathologia       Date:  1984-05-30       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.